WELLVONE Side Effects

6379468-X | Renal Failure Acute
on Sep 18, 2009 Female patient from FRANCE , 36 years of age, was treated with Wellvone (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Wellvone dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ). Patient was hospitalized.

6093999-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Cytolytic Hepatitis
Patient was taking Wellvone (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cytolytic hepatitis on Feb 18, 2009 from FRANCE Additional patient health information: Male patient , 45 years of age, . Wellvone dosage: .

6077339-X | Leukopenia
Adverse event was reported on Feb 06, 2009 by a Male patient taking Wellvone (View Usage) (Dosage: ) . Location: FRANCE , 62 years of age, After Wellvone was administered, patient had the following side effects: leukopenia. During the same period patient was treated with VFEND (View Vfend Review and Vfend Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), MABCAMPATH (View Mabcampath Review and Mabcampath Label ). Patient was hospitalized.

5789038-X | Mucous Membrane Disorder, Pyrexia, Rash, Rash Erythematous, Skin Disorder, Staphylococcal Bacteraemia, Toxic Epidermal Necrolysis
on Jun 19, 2008 Male patient from FRANCE , 24 years of age, was treated with Wellvone (View Usage). Patient experienced the following unwanted or unexpected effects: mucous membrane disorder, pyrexia, rash (What is rash?), rash erythematous, skin disorder, staphylococcal bacteraemia, toxic epidermal necrolysis. Wellvone dosage: . During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), TAHOR (View Tahor Review and Tahor Label ), AMLOR (View Amlor Review and Amlor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BRISTOPEN (1g Per Day) (View Bristopen Review and Bristopen Label ). Patient was hospitalized.


5702732-1 | Mucous Membrane Disorder, Pyrexia, Rash, Rash Erythematous, Skin Disorder, Staphylococcal Bacteraemia, Toxic Epidermal Necrolysis
on Mar 31, 2008 Male patient from FRANCE , 24 years of age, was treated with Wellvone (View Usage). Patient had the following side effects: mucous membrane disorder, pyrexia, rash (What is rash?), rash erythematous, skin disorder, staphylococcal bacteraemia, toxic epidermal necrolysis. Wellvone dosage: . During the same period patient was treated with TRIATEC (View Triatec Review and Triatec Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), AMLOR (View Amlor Review and Amlor Label ), BRISTOPEN (View Bristopen Review and Bristopen Label ). Patient was hospitalized.

5647018-9 | Enanthema, Face Oedema, Hepatocellular Injury, Lymphadenopathy, Pyrexia, Rash Maculo-papular
Patient was taking Wellvone (View Usage). After Wellvone was administered, patient had the following side effects: enanthema, face oedema, hepatocellular injury, lymphadenopathy, pyrexia, rash maculo-papular on Feb 20, 2008 from FRANCE Additional patient health information: Female patient , 32 years of age, was diagnosed with tuberculosis (What is tuberculosis?), anxiety (What is anxiety?), insomnia, candidiasis and. Wellvone dosage: . During the same period patient was treated with RIMIFON (View Rimifon Review and Rimifon Label ), RIFADIN (View Rifadin Review and Rifadin Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ), AMIKLIN (View Amiklin Review and Amiklin Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), IMOVANE (View Imovane Review and Imovane Label ), MYCOSTATIN (View Mycostatin Review and Mycostatin Label ). Patient was hospitalized.

5585587-8 | Rash, Rash Erythematous, Skin Disorder, Toxic Epidermal Necrolysis
Adverse event was reported on Dec 31, 2007 by a Male patient taking Wellvone (View Usage) (Dosage: ) . Location: FRANCE , 24 years of age, Patient experienced the following unwanted or unexpected effects: rash (What is rash?), rash erythematous, skin disorder, toxic epidermal necrolysis. During the same period patient was treated with TRIATEC (View Triatec Review and Triatec Label ), TAHOR (View Tahor Review and Tahor Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), AMLOR (View Amlor Review and Amlor Label ), BRISTOPEN (View Bristopen Review and Bristopen Label ). Patient was hospitalized.

5390099-0 | Hepatic Failure
on Jul 17, 2007 Female patient from FRANCE , child 12 years of age, was treated with Wellvone (View Usage). Patient had the following side effects: hepatic failure. Wellvone dosage: 1500mg Three Times Per Week.

5349318-9 | Agranulocytosis, Neutropenia
on May 31, 2007 Male patient from FRANCE , 72 years of age, weighting 136.7 lb, was treated with Wellvone (View Usage). After Wellvone was administered, patient had the following side effects: agranulocytosis, neutropenia. Wellvone dosage: . During the same period patient was treated with MABTHERA (630mg Cyclic) (View Mabthera Review and Mabthera Label ), FLUDARABINE PHOSPHATE (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), ENDOXAN (250mg Cyclic) (View Endoxan Review and Endoxan Label ). Patient was hospitalized.

5321458-X | Hepatic Failure
Patient was taking Wellvone (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic failure on May 02, 2007 from FRANCE Additional patient health information: Female patient , child 12 years of age, . Wellvone dosage: 1500mg Three Times Per Week.

5211977-9 | Alanine Aminotransferase Increased, Arthritis, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased
Adverse event was reported on Jan 17, 2007 by a Male patient taking Wellvone (View Usage) (Dosage: 750mg Twice Per Day) was diagnosed with pneumocystis jiroveci infection, rheumatoid arthritis (What is rheumatoid arthritis?), hypertension and. Location: FRANCE , 70 years of age, Patient had the following side effects: alanine aminotransferase increased, arthritis (What is arthritis?), aspartate aminotransferase increased, gamma-glutamyltransferase increased. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CORTICOID (View Corticoid Review and Corticoid Label ), ANTIHYPERTENSIVE (View Antihypertensive Review and Antihypertensive Label ).

5188285-8 | Alanine Aminotransferase Increased, Arthritis, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased
on Dec 14, 2006 Male patient from FRANCE , 70 years of age, was diagnosed with pneumocystis jiroveci infection, rheumatoid arthritis (What is rheumatoid arthritis?), hypertension and was treated with Wellvone (View Usage). After Wellvone was administered, patient had the following side effects: alanine aminotransferase increased, arthritis (What is arthritis?), aspartate aminotransferase increased, gamma-glutamyltransferase increased. Wellvone dosage: 750mg Twice Per Day. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CORTICOID (View Corticoid Review and Corticoid Label ), ANTIHYPERTENSIVE (View Antihypertensive Review and Antihypertensive Label ).

5168955-8 | Alanine Aminotransferase Increased, Aplasia, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Dizziness, Gamma-glutamyltransferase Increased, Headache, Hepatitis Acute
on Mar 16, 2006 Female patient from FRANCE , 28 years of age, was diagnosed with cerebral toxoplasmosis, herpes simplex (What is herpes simplex?) and was treated with Wellvone (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aplasia, aspartate aminotransferase increased, blood alkaline phosphatase increased, dizziness (What is dizziness?), gamma-glutamyltransferase increased, headache (What is headache?), hepatitis acute. Wellvone dosage: 750mg See Dosage Text. During the same period patient was treated with ZOVIRAX (500mg Three Times Per Day) (View Zovirax Review and Zovirax Label ), ALTHIAZIDE (View Althiazide Review and Althiazide Label ), PYRIMETHAMINE TAB (View Pyrimethamine Tab Review and Pyrimethamine Tab Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ). Patient was hospitalized.

5052616-X | Diarrhoea, Dyspnoea, Infection, Lactic Acidosis
Patient was taking Wellvone (View Usage). Patient had the following side effects: diarrhoea, dyspnoea, infection (What is infection?), lactic acidosis on Jul 07, 2006 from GERMANY Additional patient health information: Female patient , weighting 165.3 lb, was diagnosed with antibiotic prophylaxis and. Wellvone dosage: 750mg Three Times Per Week. During the same period patient was treated with ZYVOXID (View Zyvoxid Review and Zyvoxid Label ).

5025186-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Cholestasis, Dizziness, Gamma-glutamyltransferase Increased, Headache, Hepatitis Acute
Adverse event was reported on Mar 16, 2006 by a Female patient taking Wellvone (View Usage) (Dosage: 750mg See Dosage Text) was diagnosed with cerebral toxoplasmosis, herpes simplex (What is herpes simplex?) and. Location: FRANCE , 30 years of age, After Wellvone was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, cholestasis, dizziness (What is dizziness?), gamma-glutamyltransferase increased, headache (What is headache?), hepatitis acute. During the same period patient was treated with ZOVIRAX (500mg Per Day) (View Zovirax Review and Zovirax Label ), ALTHIAZIDE (View Althiazide Review and Althiazide Label ), PYRIMETHAMINE TAB (View Pyrimethamine Tab Review and Pyrimethamine Tab Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ). Patient was hospitalized.

4963077-0 | Blood Pressure Decreased, Cardiogenic Shock, Cardiopulmonary Failure, Hypersensitivity, Malabsorption, Malaise, Paraesthesia, Pneumocystis Jiroveci Pneumonia
on Nov 14, 2005 Male patient from FRANCE , 42 years of age, weighting 97.00 lb, was diagnosed with pneumocystis jiroveci pneumonia and was treated with Wellvone (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, cardiogenic shock, cardiopulmonary failure, hypersensitivity, malabsorption, malaise, paraesthesia, pneumocystis jiroveci pneumonia. Wellvone dosage: 7.5ml Twice Per Day. During the same period patient was treated with PENTACARINAT (View Pentacarinat Review and Pentacarinat Label ), PYRIMETHAMINE TAB (View Pyrimethamine Tab Review and Pyrimethamine Tab Label ).

4947814-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Dizziness, Gamma-glutamyltransferase Increased, Headache, Pyrexia, Rash Maculo-papular
on Mar 16, 2006 Female patient from FRANCE , 30 years of age, was diagnosed with cerebral toxoplasmosis and was treated with Wellvone (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, dizziness (What is dizziness?), gamma-glutamyltransferase increased, headache (What is headache?), pyrexia, rash maculo-papular. Wellvone dosage: 750mg See Dosage Text. During the same period patient was treated with ALTHIAZIDE (View Althiazide Review and Althiazide Label ), PYRIMETHAMINE TAB (View Pyrimethamine Tab Review and Pyrimethamine Tab Label ), HYDRALAZINE (View Hydralazine Review and Hydralazine Label ). Patient was hospitalized.

4841341-3 | Blood Creatinine Increased, Haematuria, Hypoalbuminaemia, Proteinuria, Renal Tubular Disorder
Patient was taking Wellvone (View Usage). After Wellvone was administered, patient had the following side effects: blood creatinine increased, haematuria, hypoalbuminaemia, proteinuria, renal tubular disorder on Nov 22, 2005 from FRANCE Additional patient health information: Female patient , 43 years of age, was diagnosed with histoplasmosis disseminated and. Wellvone dosage: 15ml Per Day. During the same period patient was treated with FUNGIZONE (View Fungizone Review and Fungizone Label ), SMECTA (3unit Per Day) (View Smecta Review and Smecta Label ), FOSCAVIR (3.5g Twice Per Day) (View Foscavir Review and Foscavir Label ), ACETAMINOPHEN (1g Three Times Per Day) (View Acetaminophen Review and Acetaminophen Label ), NEXIUM (1unit Per Day) (View Nexium Review and Nexium Label ), VFEND (View Vfend Review and Vfend Label ). Patient was hospitalized.

4829290-8 | Anaemia, Blood Disorder, Haematology Test Abnormal
Adverse event was reported on Nov 11, 2005 by a Male patient taking Wellvone (View Usage) (Dosage: 30mgk Per Day) . Location: UNITED KINGDOM , 13 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, blood disorder, haematology test abnormal.

4706494-6 | Dyspnoea Exertional, Pulmonary Embolism
on Jun 24, 2005 Female patient from FRANCE , 57 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with Wellvone (View Usage). Patient had the following side effects: dyspnoea exertional, pulmonary embolism (What is pulmonary embolism?). Wellvone dosage: 1unit Twice Per Day. During the same period patient was treated with KALETRA (2unit Three Times Per Day) (View Kaletra Review and Kaletra Label ), EMTRIVA (1unit Per Day) (View Emtriva Review and Emtriva Label ).

4645220-6 | Agranulocytosis, Bacterial Sepsis, Febrile Bone Marrow Aplasia, Systemic Candida
on Jan 10, 2005 Female patient from , 38 years of age, weighting 165.3 lb, was diagnosed with infection prophylaxis, hiv infection (What is hiv infection?), mouth ulceration, pain (What is pain?), injection and was treated with Wellvone (View Usage). After Wellvone was administered, patient had the following side effects: agranulocytosis, bacterial sepsis, febrile bone marrow aplasia, systemic candida. Wellvone dosage: 750mg Twice Per Day. During the same period patient was treated with COMBIVIR (2tab Per Day) (View Combivir Review and Combivir Label ), FORTUM (3g Per Day) (View Fortum Review and Fortum Label ), OFLOCET (400mg Per Day) (View Oflocet Review and Oflocet Label ), THALIDOMIDE (View Thalidomide Review and Thalidomide Label ), TOPALGIC ( FRANCE ) (150mg Per Day) (View Topalgic ( France ) Review and Topalgic ( France ) Label ), DAFALGAN (3g Per Day) (View Dafalgan Review and Dafalgan Label ), AMIKACIN (750mg Per Day) (View Amikacin Review and Amikacin Label ). Patient was hospitalized.

4567198-6 | Agranulocytosis, Bacterial Sepsis, Febrile Bone Marrow Aplasia
Patient was taking Wellvone (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, bacterial sepsis, febrile bone marrow aplasia on Jan 10, 2005 from Additional patient health information: Female patient , 38 years of age, weighting 165.3 lb, was diagnosed with hiv infection (What is hiv infection?), pain (What is pain?), injection and. Wellvone dosage: 750mg Twice Per Day. During the same period patient was treated with COMBIVIR (2tab Per Day) (View Combivir Review and Combivir Label ), CEFTAZIDIME (3g Per Day) (View Ceftazidime Review and Ceftazidime Label ), OFLOCET (400mg Per Day) (View Oflocet Review and Oflocet Label ), THALIDOMIDE (View Thalidomide Review and Thalidomide Label ), TOPALGIC ( FRANCE ) (150mg Per Day) (View Topalgic ( France ) Review and Topalgic ( France ) Label ), ACETAMINOPHEN (3g Per Day) (View Acetaminophen Review and Acetaminophen Label ), AMIKACIN SULFATE (750mg Per Day) (View Amikacin Sulfate Review and Amikacin Sulfate Label ). Patient was hospitalized.

4554305-4 | Agranulocytosis, Mouth Ulceration, Viral Infection
Adverse event was reported on Jan 10, 2005 by a Female patient taking Wellvone (View Usage) (Dosage: ) was diagnosed with infection prophylaxis, hiv infection (What is hiv infection?), mouth ulceration, neutropenia and. Location: , 38 years of age, Patient had the following side effects: agranulocytosis, mouth ulceration, viral infection (What is viral infection?). During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), THALIDOMIDE (View Thalidomide Review and Thalidomide Label ), GROWTH FACTOR (View Growth Factor Review and Growth Factor Label ).